US Broker Ratings

The Cooper Companies, Inc. (COO)

⚠️ No article content returned.

..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Exploring a 39% Potential Upside and Robust Revenue Growth

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) has made significant strides in the biotechnology sector, leveraging cutting-edge RNA interference technology to develop therapeutics for a range of diseases...

UnitedHealth Group (UNH) Stock Analysis: 18.61% Potential Upside Amid Robust Growth and Dividends

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector with a market capitalization of $276.23 billion, offers a compelling opportunity for investors seeking stability..

Natera, Inc. (NTRA) Stock Analysis: A $27.36 Billion Leader in Diagnostics with 33.96% Upside Potential

Natera, Inc. (NTRA), a prominent player in the healthcare sector, is garnering attention from investors with its cutting-edge diagnostics and research services. Headquartered in Austin, Texas,..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Uncovering a 13% Potential Upside in the Diagnostics & Research Sector

Mettler-Toledo International, Inc. (NYSE: MTD), a leader in precision instruments and services, presents an intriguing opportunity for investors in the healthcare sector, particularly within the diagnostics..

Sanofi (SNY) Stock Analysis: Exploring a 22% Potential Upside Amidst Strong Buy Ratings

Sanofi (NASDAQ: SNY), a prominent player in the healthcare sector, is capturing investor attention with a market capitalization of $113.88 billion. Headquartered in Paris, France, the..

Humana Inc. (HUM) Stock Analysis: Navigating a 10.37% Potential Upside in Healthcare Plans

As one of the leading players in the healthcare plans sector, Humana Inc. (NYSE: HUM) presents a compelling opportunity for investors seeking exposure to the healthcare..

The Cigna Group (CI) Stock Analysis: Exploring a 24.9% Potential Upside

Investors eyeing opportunities in the healthcare sector may find The Cigna Group (NYSE: CI) a compelling candidate, given its robust market position and promising growth metrics...

GSK plc (GSK) Investor Outlook: Evaluating the Healthcare Giant’s Potential Amidst a 3.05% Dividend Yield

GSK plc (NYSE: GSK) stands as a formidable player in the healthcare sector, primarily engaged in the research, development, and manufacture of vaccines and specialty medicines...

Danaher Corporation (DHR) Stock Analysis: Unveiling a 37.84% Potential Upside for Savvy Investors

Danaher Corporation (NYSE: DHR) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $134.19..

Johnson & Johnson (JNJ) Stock Analysis: Navigating Growth with a 1.45% Potential Upside

Johnson & Johnson (NYSE: JNJ), a titan in the healthcare sector, continues to capture investor attention with its robust market presence and strategic positioning in the..

Atrium Therapeutics, Inc. (RNA) Stock Analysis: Uncovering a Potential 86% Upside

Atrium Therapeutics, Inc. (NASDAQ: RNA) is making waves in the biotechnology sector as an emergent player in RNA-based therapies. With a focus on cardiomyopathies, the company..

Bausch + Lomb (BLCO) Stock Analysis: Eyeing an 11.96% Upside with Strategic Growth in Global Eye Health

Bausch + Lomb Corporation (NYSE: BLCO), a stalwart in the healthcare sector under the Medical Instruments & Supplies industry, has been crafting a significant presence in..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A 20% Upside Potential Beckons Investors

Krystal Biotech, Inc. (NASDAQ: KRYS), a prominent player in the biotechnology sector, continues to capture investor interest with its impressive market capitalization of $7.63 billion. As..

BridgeBio Pharma, Inc. (BBIO): Analyst Consensus Sees 37.58% Upside Potential in Biotech Innovator

BridgeBio Pharma, Inc. (NASDAQ: BBIO) has emerged as a focal point for investors keen on the biotechnology sector, thanks to its dynamic approach to addressing genetic..

Prestige Consumer Healthcare (PBH) Stock Analysis: A 49.58% Upside Potential with Strong Buy Ratings

Prestige Consumer Healthcare Inc. (NYSE: PBH) stands out in the healthcare sector as a key player in the over-the-counter (OTC) health and personal care market. With..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a 20% Potential Upside for Investors

Lantheus Holdings, Inc. (NASDAQ: LNTH) stands as a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Based in Bedford,..

Alkermes plc (ALKS) Stock Analysis: Evaluating a 25% Potential Upside Amidst Market Challenges

Alkermes plc (NASDAQ: ALKS), the Dublin-based biopharmaceutical company, presents an intriguing investment opportunity within the healthcare sector, specifically in the specialty and generic drug manufacturing industry...

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 32.5% Upside Potential in Biotech

TG Therapeutics, Inc. (NASDAQ: TGTX), a prominent player in the biotechnology sector, stands out as a compelling investment opportunity, particularly for those interested in healthcare innovations...

Halozyme Therapeutics, Inc. (HALO): Investor Outlook Reveals 31.63% Upside Potential in Biotech Sector

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology industry, is drawing attention from investors with its impressive valuation metrics and strategic partnerships. With..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds